{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:32:50Z","timestamp":1761093170735,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.urolonc.2022.08.011","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T03:19:08Z","timestamp":1666322348000},"page":"254.e1-254.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria"],"prefix":"10.1016","volume":"41","author":[{"given":"Eva Charlotte","family":"Kuckuck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Hennenlotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Todenh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenuta-Ancuta","family":"Br\u00fcnn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg-Christian","family":"Rass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Roghmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Goebell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Oliver","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Pycha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bolenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Benderska-S\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-1857","authenticated-orcid":false,"given":"Bernd J.","family":"Schmitz-Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2022.08.011_bib0001","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0002","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.urolonc.2016.05.030","article-title":"Microhematuria assessment \u2013 a comprehensive review of current guidelines","volume":"34","author":"Schmitz-Dr\u00e4ger","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0003","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.juro.2010.12.093","article-title":"Association of hematuria on microscopic urinalysis and risk of urinary tract cancer","volume":"185","author":"Jung","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0004","first-page":"1145","article-title":"Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations","volume":"63","author":"Grossfeld","year":"2001","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0005","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","article-title":"American Urological Association. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5489\/cuaj.1029","article-title":"Canadian guidelines for the management of asymptomatic microscopic hematuria in adults","volume":"3","author":"Wollin","year":"2009","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0007","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10157-014-1001-2","article-title":"Japanese guidelines of the management of hematuria 2013","volume":"18","author":"Horie","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0008","doi-asserted-by":"crossref","DOI":"10.3310\/hta10180","article-title":"Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation","volume":"10","author":"Rodgers","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0009","article-title":"Joint Consensus Statement on the Initial Assessment of Haematuria","author":"Anderson","year":"2008","journal-title":"BAUS"},{"year":"2010","series-title":"Nederlandse Vereniging voor Urologie. Richtlijn Hematurie","author":"Hovius","key":"10.1016\/j.urolonc.2022.08.011_bib0010"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0011","first-page":"4911","article-title":"[Microscopic hematuria in adults\u2013a diagnostic dilemma. Scientific guidelines for management are not available according to a review of the literature]","volume":"96","author":"K\u00f6hler","year":"1999","journal-title":"Lakartidningen"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0012","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/bmj.326.7393.813","article-title":"Time to abandon testing for microscopic haematuria in adults?","volume":"326","author":"Malmstr\u00f6m","year":"2003","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.urolonc.2022.08.011_bib0013","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0014","unstructured":"https:\/\/www.nice.org.uk\/guidance\/ng12\/chapter\/1-Recommendations-organised-by-site-of-cancer (last approach 11\/27\/2021)"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0015","unstructured":"Jefferies ER, Brewster SF on behalf of BAUS section of oncology 2015.https:\/\/www.baus.org.uk\/_userfiles\/pages\/files\/Publications\/BAUS%20Cancer%20Guidelines%20Summary.pdf (last approach 11\/27\/2021)"},{"issue":"1-2","key":"10.1016\/j.urolonc.2022.08.011_bib0016","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.5489\/cuaj.3583","article-title":"Recommendations for the improvement of bladder cancer quality of care in Canada: a consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015","volume":"10","author":"Kassouf","year":"2016","journal-title":"Can Urol Assoc J."},{"key":"10.1016\/j.urolonc.2022.08.011_bib0017","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5489\/cuaj.10059","article-title":"Patients with microscopic and gross hematuria: practice and referral patterns among primary care physicians in a universal health care system","volume":"5","author":"Yafi","year":"2011","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.urolonc.2008.10.018","article-title":"Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey","volume":"28","author":"Nieder","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0019","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00345-012-0979-x","article-title":"Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer","volume":"30","author":"Cha","year":"2012","journal-title":"World J Urol"},{"year":"2010","series-title":"AJCC Cancer Staging Handbook","key":"10.1016\/j.urolonc.2022.08.011_bib0020"},{"year":"2004","series-title":"Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","key":"10.1016\/j.urolonc.2022.08.011_bib0021"},{"issue":"2","key":"10.1016\/j.urolonc.2022.08.011_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bju.14016","article-title":"Guideline of guidelines: asymptomatic microscopic haematuria","volume":"121","author":"Linder","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0023","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-4295(99)80006-5","article-title":"Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations","volume":"45","author":"Messing","year":"1995","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0024","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-5347(01)67224-0","article-title":"Hematuria home screening: repeat testing results","volume":"154","author":"Messing","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0025","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/cncr.22224","article-title":"Long-term outcome of hematuria home screening for bladder cancer in men","volume":"107","author":"Messing","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0026","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2010.09521.x","article-title":"Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up","volume":"107","author":"Edwards","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0027","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/JU.0000000000001550","article-title":"Evaluation of the New American Urological Association Guidelines Risk Classification for Hematuria","volume":"205","author":"Woldu","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0028","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamainternmed.2019.2280","article-title":"Comparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuria","volume":"179","author":"Georgieva","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0029","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2011.08.073","article-title":"Immunocytology is a strong predictor of bladder cancer presence in patients with asymptomatic hematuria: a multicenter study","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0030","doi-asserted-by":"crossref","first-page":"e77657","DOI":"10.1371\/journal.pone.0077657","article-title":"The use of molecular analyses in voided urine for the assessment of patients with hematuria","volume":"8","author":"Beukers","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0031","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/00365590500368807","article-title":"Screening for bladder tumours in men aged 60-70 years with a bladder tumour marker (UBC) and dipstick-detected haematuria using both white-light and fluorescence cystoscopy","volume":"40","author":"Hedelin","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.urolonc.2022.08.011_bib0032","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","article-title":"The Paris System for reporting urinary cytology: the quest to develop a standardized terminology","volume":"23","author":"Barkan","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2022.08.011_bib0033","first-page":"125","article-title":"[How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre]","volume":"55","author":"Ulldemolins Aznar","year":"2022","journal-title":"Rev Esp Patol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922003040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:26:37Z","timestamp":1761042397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922003040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1078143922003040"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discriminative capacity of guideline recommendations in the assessment of patients with asymptomatic microhematuria","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}